Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. Benzinga · Jul 1, 2022
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. Benzinga · Jun 30, 2022
Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 29 stocks hit new 52-week lows. Benzinga · Mar 30, 2022
Revelation Biosciences And 3 Other Penny Stocks Bought By Insiders Although gold prices traded almost flat this morning on Wednesday, there were a few notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or… Benzinga · Feb 9, 2022